chrM-12192-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The ENST00000387441.1(MT-TH):n.55G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Mitomap GenBank:
𝑓 0.0021 ( AC: 126 )
Consequence
MT-TH
ENST00000387441.1 non_coding_transcript_exon
ENST00000387441.1 non_coding_transcript_exon
Scores
Mitotip
Benign
Clinical Significance
MICM-/-possible-G15927A-deafness-modulator
Conservation
PhyloP100: -4.60
Genes affected
MT-TH (HGNC:7487): (mitochondrially encoded tRNA histidine)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Mitotip and hmtvar scores support benign criterium.
BP6
Variant M-12192-G-A is Benign according to our data. Variant chrM-12192-G-A is described in ClinVar as [Benign]. Clinvar id is 9608.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomadMitoHomoplasmic at 223
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNH | TRNH.1 use as main transcript | n.55G>A | non_coding_transcript_exon_variant | 1/1 | ||||
TRNS2 | TRNS2.1 use as main transcript | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-TH | ENST00000387441.1 | n.55G>A | non_coding_transcript_exon_variant | 1/1 | ||||||
MT-TS2 | ENST00000387449.1 | upstream_gene_variant |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
126
Gnomad homoplasmic
AF:
AC:
223
AN:
56428
Gnomad heteroplasmic
AF:
AC:
3
AN:
56428
Mitomap
MICM-/-possible-G15927A-deafness-modulator
ClinVar
Significance: Benign
Submissions summary: Pathogenic:2Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cardiomyopathy, hypertrophic, mitochondrial Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2003 | - - |
Cardiomyopathy, idiopathic dilated, mitochondrial Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2003 | - - |
Juvenile myopathy, encephalopathy, lactic acidosis AND stroke Benign:1
Benign, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Jul 12, 2019 | The NC_012920.1:m.12192G>A variant in MT-TH gene is interpreted to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: BS1, BS2, BP4 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Benign
Hmtvar
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at